Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceC-PIREFLDQYDAPL
    • Amino acids213 to 225

Associated products

Specifications

Our Abpromise guarantee covers the use of ab22776 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-SOCS3 antibody (ab723)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • ATOD4
    • CIS 3
    • CIS-3
    • CIS3
    • Cish3
    • Cytokine induced SH2 protein 3
    • Cytokine-inducible SH2 protein 3
    • E2a Pbx1 target gene in fibroblasts 10
    • EF 10
    • MGC71791
    • SOCS 3
    • SOCS-3
    • Socs3
    • SOCS3_HUMAN
    • SSI 3
    • SSI-3
    • SSI3
    • STAT induced STAT inhibitor 3
    • STAT-induced STAT inhibitor 3
    • Suppressor of cytokine signaling 3
    see all
  • FunctionSOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS3 is involved in negative regulation of cytokines that signal through the JAK/STAT pathway. Inhibits cytokine signal transduction by binding to tyrosine kinase receptors including gp130, LIF, erythropoietin, insulin, IL12, GCSF and leptin receptors. Binding to JAK2 inhibits its kinase activity. Suppresses fetal liver erythropoiesis. Regulates onset and maintenance of allergic responses mediated by T-helper type 2 cells. Regulates IL-6 signaling in vivo (By similarity). Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Seems to recognize IL6ST.
  • Tissue specificityWidely expressed with high expression in heart, placenta, skeletal muscle, peripheral blood leukocytes, fetal and adult lung, and fetal liver and kidney. Lower levels in thymus.
  • PathwayProtein modification; protein ubiquitination.
  • Involvement in diseaseNote=There is some evidence that SOCS3 may be a susceptibility gene for atopic dermatitis linked to 17q25. SOCS3 messenger RNA is significantly more highly expressed in skin from patients with atopic dermatitis than in skin from healthy controls. Furthermore, a genetic association between atopic dermatitis and a haplotype in the SOCS3 gene has been found in two independent groups of patients.
  • Sequence similaritiesContains 1 SH2 domain.
    Contains 1 SOCS box domain.
  • DomainThe ESS and SH2 domains are required for JAK phosphotyrosine binding. Further interaction with the KIR domain is necessary for signal and kinase inhibition.
    The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin ligase complexes.
  • Post-translational
    modifications
    Phosphorylated on tyrosine residues after stimulation by the cytokines, IL-2, EPO or IGF1.
  • Information by UniProt

References for Human SOCS3 peptide (ab22776)

ab22776 has not yet been referenced specifically in any publications.

Product Wall

Thank you for getting back in touch with me. Both SOCS1 antibody (ab3691) Rabbit Polyclonal IgG and SOCS3 antibody [SO1] (ab14939) Mouse Monoclonal IgG2b require secondary antibodies for the detection as neither are directly conjugated with fluores...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"